Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPharos Energy Regulatory News (PHAR)

Share Price Information for Pharos Energy (PHAR)

Share Price is delayed by 15 minutes
Get Live Data
25.10    -0.30 (-1.18%)
Bid:
24.70
Ask:
25.20
Spread: 0.50 (2.024%)
Market Cap: £103.94m
PHAR Live PriceLast checked at - London Stock Exchange

Intraday Pharos Energy Share Chart

Form 8.3 - Pharos Energy plc

Today 15:15

Aberforth Partners LLP - Form 8.3 - Pharos Energy plc

Aberforth Partners LLP - Form 8.3 - Pharos Energy plc

PR Newswire

LONDON, United Kingdom, June 24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1.   KEY INFORMATION

(a)   Full name of discloser:

Aberforth Partners LLP, on behalf of discretionary clients.

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):

  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

Pharos Energy plc

 

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e)   Date position held/dealing undertaken:

  For an opening position disclosure, state the latest practicable date prior to the disclosure

23/06/2026

 

(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

  If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2.   POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)   Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled:

59,357,027

14.258%

 

0

 

0.0

(2)   Cash-settled derivatives:

 

 

(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

  TOTAL:

59,357,027

14.258%

 

0

 

0.0

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)   Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3.   DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)   Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

N/A- Opening Disclosure

(b)   Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

(c)   Stock-settled derivative transactions (including options)

(i)   Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

(ii)   Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

(d)   Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

4.   OTHER INFORMATION

(a)   Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)   Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)   the voting rights of any relevant securities under any option; or

(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c)   Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

 

24 June 2026

Contact name:

Michael Campbell, for Aberforth Partners LLP

Telephone number:

0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 



Date   Source Headline
29th Jul 20217:00 amRNSVietnam Operational and RBL Update
21st Jul 20217:00 amRNSVietnam Operational Update
14th Jul 20217:00 amRNSTrading and Operations Update
29th Jun 202110:55 amRNSTR-1
10th Jun 20215:38 pmRNSExternal Directorship
10th Jun 20217:00 amRNSActivity Update
8th Jun 202111:34 amRNSResults of Annual General Meeting
1st Jun 20217:00 amRNS2021 AGM Trading and Operations Update
30th Apr 20219:11 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20217:30 amRNSExternal Directorship
12th Apr 20214:15 pmRNSInvestor Presentation
7th Apr 20217:00 amRNS2020 Preliminary Results
30th Mar 20217:00 amRNSConcession Agreement Amendment El Fayum area
17th Mar 20217:00 amRNSBoard Change
24th Feb 20217:00 amRNSNotice of Results
1st Feb 20217:30 amRNSDirector/PDMR Shareholding
29th Jan 20213:56 pmRNSHolding(s) in Company
28th Jan 20214:00 pmRNSTotal Voting Rights
27th Jan 202112:51 pmRNSHolding(s) in Company
27th Jan 202111:08 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSResults of Placing
21st Jan 20215:59 pmRNSRetail Offer via PrimaryBid.com
21st Jan 20215:41 pmRNSProposed Placing, Subscription and Retail Offer
13th Jan 20217:00 amRNSTrading and Operations Update January 2021
3rd Dec 202010:31 amRNSChange of registered address
4th Nov 20204:40 pmRNSSecond Price Monitoring Extn
4th Nov 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20204:35 pmRNSPrice Monitoring Extension
26th Oct 20204:41 pmRNSSecond Price Monitoring Extn
26th Oct 20204:35 pmRNSPrice Monitoring Extension
14th Oct 20204:40 pmRNSSecond Price Monitoring Extn
14th Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20204:41 pmRNSSecond Price Monitoring Extn
12th Oct 20204:36 pmRNSPrice Monitoring Extension
6th Oct 20204:35 pmRNSPrice Monitoring Extension
1st Oct 20204:40 pmRNSSecond Price Monitoring Extn
1st Oct 20204:36 pmRNSPrice Monitoring Extension
21st Sep 20204:41 pmRNSSecond Price Monitoring Extn
21st Sep 20204:35 pmRNSPrice Monitoring Extension
17th Sep 20204:40 pmRNSSecond Price Monitoring Extn
17th Sep 20204:35 pmRNSPrice Monitoring Extension
11th Sep 20207:00 amRNSTGT Full Field Development Plan Approval
1st Sep 202012:07 pmRNSSecond Price Monitoring Extn
1st Sep 202012:02 pmRNSPrice Monitoring Extension
26th Aug 20207:00 amRNSInterim results for the Half-year to 30 June 2020
4th Aug 20207:00 amRNSTGT field licence extension and RBL Update
30th Jul 20207:00 amRNSNotice of Results
9th Jul 20207:00 amRNSTrading and Operations Update
22nd Jun 202011:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.